Morphological features and differential diagnosis of hepatitis C recurrence after liver transplantation - literature review and results of single transplantation center

Annals of Transplantation

Volumn 13, Issue 2, 2008, Pages 12-20

  Ziarkiewicz Wróblewska, Bogna ^a   Wróblewski, Tadeusz ^a   Wasiutyński, Aleksander ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

HCV reinfection; Histopathology; Liver transplantation

Indexed keywords

EOSIN; HEMATOXYLIN;

BILE DUCT; CELL DEGENERATION; CELL INFILTRATION; CELL VACUOLE; CLINICAL FEATURE; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; EOSINOPHILIA; GRAFT REJECTION; HEPATITIS C; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LIVER BIOPSY; LIVER TRANSPLANTATION; MORPHOLOGY; NECROSIS; REINFECTION; REVIEW; STAINING; STEATOSIS; VASCULITIS; VIRUS LOAD; VIRUS VIRULENCE; PATHOLOGY; RECURRENT DISEASE; RISK FACTOR;

DIAGNOSIS, DIFFERENTIAL; GRAFT REJECTION; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; RECURRENCE; RISK FACTORS;

EID: 59649083515     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Berenguer M, Lake J: Hepatitis C and Liver Transplantation. Chapter 10: Busuttil R. and Klintmalm G. Transplantation of the liver. 2nd ed. Philadelphia: Saunders, 2005
2. Ziółkowski J, Niewczas M, Senatorski G et al: Liver Transplantation in hepatitis C virus-related cirrhosis. Transplant Proc, 2003; 35: 2275-2277
3. Neumann UM, Berg T, Bahra M et al: Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. Hepatol, 2004; 41: 830-836
4. Burt D, Portmann BC, Ferrell L: MacSween's Pathology of the Liver. 5th ed. Churchill Livingstone, 2007
5. Ghobrial RM, Steadman R, Gornbein J et al: A 10- year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg, 2001; 234: 384-394
6. Gane EJ, Portmann BC, Naoumov NV et al: Longterm outcome of hepatitis C infection after liver transplantation. N Engl J Med, 1996; 28(334): 815-820
7. Berenguer M, Crippin J, Gish R et al: A model to predict severe WZWC-related disease following liver transplantation. Hepatology, 2003; 38: 34-41
8. Wiesner RH, Sorell M, Villamil F: Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on Liver Transplantation and Hepatitis C. Liver Transpl, 2003; 9(Suppl.3): S1-S9
9. Firpi RJ, Abdelmalek MF, Soldevila-Pico C et al: One-year protocol liver biopsy can stratify fi brosis progression in liver transplant recipients with recurrent hepatitis C infection. Liver Transpl, 2004; 10: 1240-1247
10. Adam R, McMaster P, O'Grady JG et al: Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl, 2003; 9: 1231-1243
11. Cameron AM, Ghobrial RM, Hiatt JR et al: Effect of nonviral factors on hepatitis C recurrence after liver transplantation. Ann Surg, 2006; 244: 563-571
12. Burak KW, Kremers WK, Batts KP et al: Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl, 2002; 8: 362-369
13. Abt PL, Mange KC, Olthoff KM et al: Allograft sur vival following adult-to-adult living donor liver transplantation, Am J Transplant, 2004; 4: 1302-1307
14. Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y et al: Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology, 2000; 32: 1125-1130
15. Watt KDS, Lyden ER, Gulizia JM, McCashland TM: Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome. Liver Transpl, 2006; 12: 134-139
16. Velidedeoglu E, Desai NM, Campos L et al: The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation, 2002; 73: 582-587
17. Forman LM, Lewis JD, Berlin JA et al: The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology, 2002; 122: 889-896
18. Humar A, Kumar D, Raboud J et al: Interaction between cytomegalovirus, human herpesvirus-6, and the recurrence of hepatitis C after liver transplantation. Am J Transplant, 2002; 2: 461-466
19. Testa G, Crippin JS, Netto GJ et al: Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl, 2000; 6: 553-561
20. Neuberger J, Schulz KH, Day C et al: Transplantation for alcoholic liver disease. J Hepatol, 2002; 36: 130-137
21. Langrehr JM, Puhl G, Bahra M et al: Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation. Liver Transpl, 2006; 12(4): 644-651
22. Ercolani G, Grazi GL, Ravaioli M et al: Histological recurrent hepatitis C after liver transplantation: outcome and role of retransplantation. Liver Transpl, 2006; 12: 1104-1111
23. Lassman C: Pathology of recurrence of non-neoplastic disease after liver transplantation. Chapter 70th in: Busuttil R and Klintmalm G. Transplantation of the liver. Transplantation of the liver. 2nd ed. Filadelfi a: Saunders, 2005
24. Rakela J, Vargas HE: Hepatitis C: magnitude of the problem. Liver Transpl, 2002; 8(10 Suppl.): S3-S6
25. Ghobrial R: Retransplantation for recurrent hepatitis C. Liver Transpl, 2002; 8: S38-S43
26. Saab S, Hu R, Ibrahim AB et al: Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C. Am J Transpl, 2003; 3: 328-333
27. Ziarkiewicz-Wrólewska B, Gónicka B, Ołdakowska- Jedynak U et al: Morphologic features of hepatitis C recurrence in patients after orthotopic liver transplantation-preliminary analysis of our case observations. Transplant Proc, 2006; 38: 226-230
28. Guido M, Fagiuoli S, Tessari G et al: Histology predicts cirrhotic evolution of post transplant hepatitis C. Gut 2002; 50: 697-700
29. Gónicka B, Ziarkiewicz-Wrólewska B: Histopatologia zmian w przeszczepie watroby. In: Rowiński W, Wałaszewski J, Paczek L. Transplantologia kliniczna. 1st ed. Warszawa, Wydawnictwo Lekarskie PZWL, 2004: 195-206
30. McCaughan GW, Zekry A: Mechanisms of WZWC reinfection and allograft damage after liver transplantation. J Hepatol, 2004; 40: 368-374
31. Vallet-Pichard A, Pol S: Natural history and predictors of severity of chronic hepatitis C virus (WZWC) and human immunodeficiency virus (HIV) co-infection. J Hepatol, 2006; 44(1 Suppl.): S28-S34
32. Rosenberg PM, Farrell JJ, Abraczinskas DR et al: Rapidly progressive fibrosing cholestatic hepatitis- hepatitis C virus in HIV coinfection. Am J Gastroenterol, 2002; 97: 478-483
33. Charlton M, Seaborg E: Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of National Institute of Diabetes and Digestive and Kidney Diseases, Liver Transplantation Database. Liver Transpl Surg, 5(Suppl.): S107-S114
34. International Panel. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology, 1997; 25: 658-663
35. Demetris AJ, Eghtesad B, Marcos A et al: Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol, 2004; 28: 658-669
36. Burton JR Jr, Rosen HR: Acute rejection in HCV-infected liver transplant recipients: The great conundrum. Liver Transpl, 2006; 12: S38-S47